CD8A and neoplasm: We also provide further evidence to highlight the importance of CD8 T-cells and CD20 B-cells by further stratifying the risk of recurrence where low-CD8, high-CD20 tumours exhibited more than twice the risk of LR of double-high tumours (HR 2.7, CI 1.2–6.2, p = 0.016).